Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Researchers.
- Curriculum.
- Publications.
- Projects.
- Presentations.
Institutions.
Projects.
Publications.
Partners.
Sponsors.
Equipment.
Knowhow.
Fields of Research.

Schwegel Nora |

Publications

** = Publications listed in SCI/SSCI/Pubmed

2025

Full paper/article (Journal)

** Cejka, V; Riepl, H; Schwegel, N; Kolesnik, E; Zach, D; Santner, V; Höller, V; Schweighofer, N; Obermayer-Pietsch, B; Pieber, T; Morbach, C; Frantz, S; Zirlik, A; von, Lewinski, D; Störk, S; Posch, F; Ablasser, K; Verheyen, N Prognostic impact of gait speed, muscle strength and muscle mass in chronic heart failure-A prospective cohort study.
ESC Heart Fail. 2025; 12(3):2113-2124 Doi: 10.1002/ehf2.15221 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Schwegel, N; Strohhofer, C; Kolesnik, E; Oltean, S; Hüttmair, A; Pipp, C; Benedikt, M; Verheyen, N; Gollmer, J; Ablasser, K; Wallner, M; Santner, V; Tripolt, N; Pferschy, P; Zechner, P; Alber, H; Siller-Matula, JM; Kopp, K; Zirlik, A; Aziz, F; Sourij, H; von, Lewinski, D Impact of empagliflozin on cardiac structure and function assessed by echocardiography after myocardial infarction: a post-hoc sub-analysis of the emmy trial.
Clin Res Cardiol. 2025; 114(5):629-639 Doi: 10.1007/s00392-024-02523-1 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

2024

Full paper/article (Journal)

** Schwegel, N; Toferer, C; Zach, DK; Santner, V; Höller, V; Lugitsch, J; Wallner, M; Gollmer, J; Aziz, F; von, Lewinski, D; Kolesnik, E; Ablasser, K; Zirlik, A; Sourij, H; Verheyen, N Impact of SGLT2-Inhibitor Therapy on Survival in Patients with Transthyretin Amyloid Cardiomyopathy: Analysis of a Prospective Registry Study.
J Clin Med. 2024; 13(19): Doi: 10.3390/jcm13195966 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Schwegel, N; Zach, D; Peikert, A; Santner, V; Höller, V; Gollmer, J; Späth, J; Riepl, H; Rainer, PP; Wallner, M; Pilz, S; Zirlik, A; von, Lewinski, D; Ablasser, K; Verheyen, N; Kolesnik, E The Prognostic Value of Right Ventricular Function in Patients with Chronic Heart Failure-A Prospective Study.
J Clin Med. 2024; 13(7): 1930 Doi: 10.3390/jcm13071930 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Verheyen, N; Schmid, J; Kolesnik, E; Schwegel, N; Späth, J; Kattnig, L; Riepl, H; Zach, D; Santner, V; Höller, V; Pilz, S; Tomaschitz, A; Fuchsjäger, M; Fahrleitner-Pammer, A; Dimai, HP; Obermayer-Pietsch, B; Fruhwald, F; Scherr, D; Zirlik, A; von, Lewinski, D; Ablasser, K Prevalence and prognostic impact of bone disease in chronic heart failure with reduced ejection fraction.
ESC Heart Fail. 2024; 11(3):1730-1738 Doi: 10.1002/ehf2.14741 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Zach, DK; Schwegel, N; Santner, V; Winkelbauer, L; Hoeller, V; Kolesnik, E; Gollmer, J; Seggewiss, H; Batzner, A; Perl, S; Wallner, M; Reiter, U; Rainer, PP; Zirlik, A; Ablasser, K; Verheyen, N Low-grade systemic inflammation and left ventricular dysfunction in hypertensive compared to non-hypertensive hypertrophic cardiomyopathy.
Int J Cardiol. 2024; 399:131661 Doi: 10.1016/j.ijcard.2023.131661
Web of Science PubMed FullText FullText_MUG

Editorial

** Schwegel, N; Verheyen, N Update on the Treatment of LVOT Obstruction in HOCM
J KARDIOL. 2024; 31(7-8):
Web of Science

Abstract (Journal)

** Schwegel, N; Santner, ; Zach, DK; Hoeller, ; Wallner, M; Muendlein, A; Brandtner, EM; Leiherer, A; Drexel, H; Mader, A; Von Lewinski, D; Ablasser, K; Kolesnik, E; Zirlik, A; Verheyen, N Prognostic value of circulating glypican-4 in patients with chronic heart failure with reduced ejection fraction
EUR HEART J. 2024; 45(S1):ehae666971--ESC Congress; AUG 30-SEP 02, 2024; London, UK. Doi: 10.1093/eurheartj/ehae666.971 [Poster]
Web of Science FullText FullText_MUG

** Toferer, C; Schwegel, N; Santner, ; Zach, DK; Hoeller, ; Wallner, M; Gollmer, J; Aziz, F; Von Lewinski, D; Kolesnik, E; Ablasser, K; Zirlik, A; Sourij, H; Verheyen, N Prognostic impact of SGLT2-inhibitor therapy on survival in patients with transthyretin amyloid cardiomyopathy
EUR HEART J. 2024; 45(S1):ehae6662037--ESC Congress; AUG 30-SEP 02, 2024; London, UK. Doi: 10.1093/eurheartj/ehae666.2037 [Poster]
Web of Science FullText FullText_MUG

** Winkelbauer, L; Santner, ; Schwegel, N; Hoeller, ; Gollmer, J; Kolesnik, E; Wallner, M; Von Lewinski, D; Zirlik, A; Ablasser, K; Verheyen, N; Zach, D Left atrial reservoir strain differentiates cardiac amyloidosis and hypertrophic cardiomyopathy
EUR HEART J. 2024; 45(S1):ehae666946--ESC Congress; AUG 30-SEP 02, 2024; London, UK. Doi: 10.1093/eurheartj/ehae666.946 [Poster]
Web of Science FullText FullText_MUG

** Zach, DK; Batzner, A; Schwegel, N; Santner, ; Hoeller, ; Ablasser, K; Morbach, C; Stoerk, S; Maack, C; Reiter, U; Rainer, PP; Frantz, S; Zirlik, A; Seggewiss, H; Verheyen, N Residual mitral leaflet length independently indicates left ventricular outflow tract obstruction in hypertrophic cardiomyopathy
EUR HEART J. 2024; 45: ehae666098 Doi: 10.1093/eurheartj/ehae666.098 [Poster]
Web of Science FullText FullText_MUG

2023

Full paper/article (Journal)

** Santner, V; Riepl, HS; Posch, F; Wallner, M; Rainer, PP; Ablasser, K; Kolesnik, E; Hoeller, V; Zach, D; Schwegel, N; Kreuzer, P; Lueger, A; Petutschnigg, J; Pieske, B; Zirlik, A; Edelmann, F; Verheyen, N Non-eligibility for pivotal HFpEF/HFmrEF outcome trials and mortality in a contemporary heart failure cohort.
Eur J Intern Med. 2023; 118:73-81 Doi: 10.1016/j.ejim.2023.07.027
Web of Science PubMed FullText FullText_MUG

** von, Lewinski, D; Kolesnik, E; Aziz, F; Benedikt, M; Tripolt, NJ; Wallner, M; Pferschy, PN; von, Lewinski, F; Schwegel, N; Holman, RR; Oulhaj, A; Moertl, D; Siller-Matula, J; Sourij, H Timing of SGLT2i initiation after acute myocardial infarction.
Cardiovasc Diabetol. 2023; 22(1): 269 Doi: 10.1186/s12933-023-02000-5 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Abstract (Journal)

** Lugitsch, J; Hoeller, V; Schwegel, N; Santner, V; Gollmer, J; Kolesnik, E; Lipp, R; Niedrist, T; Rainer, P; Zirlik, A; Ablasser, K; Verheyen, N; Zach, D Interleukin-6 plasma levels predict mortality and heart failure events in cardiac transthyretin amyloidosis
EUR HEART J. 2023; 44: -Annual Meeting of the European-Society-of-Cardiology (ESC); AUG 25-28, 2023; Amsterdam, NETHERLANDS. [Poster]
Web of Science

** Lugitsch, J; Holler, V; Schwegel, N; Santner, V; Gollmer, J; Kolesnik, E; Lipp, R; Niedrist, T; Rainer, P; Zirlik, A; Ablasser, K; Verheyen, N; Zach, D Interleukin-6 plasma levels predict mortality and heart failure events in cardiac transthyretin amyloidosis
WIEN KLIN WOCHENSCHR. 2023; 135: S472-S473. [Poster]
Web of Science FullText

** Schwegel, N; Riepl, H; Spath, J; Kolesnik, E; Zach, D; Santner, V; Holler, V; Obermayer-Pietsch, B; Schmid, J; Scherr, D; von Lewinski, D; Zirlik, A; Ablasser, K; Verheyen, N Role of Comorbidities in Chronic Heart Failure-a prospective cohort study
WIEN KLIN WOCHENSCHR. 2023; 135: S477-S477.
Web of Science FullText

** Zach, D; Schwegel, N; Hoeller, V; Kolesnik, E; Gollmer, J; Reiter, U; Seggewiss, H; Batzner, A; Zirlik, A; Rainer, P; Ablasser, K; Verheyen, N Comparing indices of systemic inflammation and cardiac phenotype between hypertensive and non-hypertensive hypertrophic cardiomyopathy
EUR HEART J. 2023; 44: -Annual Meeting of the European-Society-of-Cardiology (ESC); AUG 25-28, 2023; Amsterdam, NETHERLANDS. [Poster]
Web of Science

** Zach, D; Schwegel, N; Holler, V; Kolesnik, E; Gollmer, J; Reiter, U; Seggewiss, H; Batzner, A; Zirlik, A; Rainer, P; Ablasser, K; Verheyen, N Comparing indices of systemic inflammation and cardiac phenotype in hypertensive and non-hypertensive hypertrophic cardiomyopathy
WIEN KLIN WOCHENSCHR. 2023; 135: S475-S476. [Poster]
Web of Science FullText

2021

Full paper/article (Journal)

** Höller, V; Seebacher, H; Zach, D; Schwegel, N; Ablasser, K; Kolesnik, E; Gollmer, J; Waltl, G; Rainer, PP; Verheyen, S; Zirlik, A; Verheyen, N Myocardial Deformation Analysis in MYBPC3 and MYH7 Related Sarcomeric Hypertrophic Cardiomyopathy-The Graz Hypertrophic Cardiomyopathy Registry.
Genes (Basel). 2021; 12(10): Doi: 10.3390/genes12101469 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Abstract (Journal)

** Schwegel, N; Kolesnik, E; Toth-Gayor, G; Zirlik, A; von Lewinski, D; Ablasser, K; Verheyen, N Post-processing measurement of left ventricular ejection fraction compared to direct measurement in patients with heart failure with reduced ejection fraction
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 3):S110-S110. [Poster]
Web of Science

** Schwegel, N; Kolesnik, E; Toth-Gayor, G; Zirlik, A; Von Lewinski, D; Ablasser, K; Verheyen, N Post-processing measurement of left ventricular ejection fraction compared to direct measurement in patients with heart failure with reduced ejection fraction
EUR HEART J. 2021; 42: 789-789. [Poster]
Web of Science

↑ Top of page / Navigation